Turning wood into pharmaceutical ingredients

Production of hazardous waste during drug manufacturing is a serious concern for the pharmaceutical industry. Typically, large amounts of flammable solvents are used during these processes, which usually require several steps to make structurally complex drugs. Researchers now report a method to produce pharmaceutically relevant compounds in just two or three steps, with water as the only waste product, using renewable woodchips as starting material.

Read more

Mapping international drug use through the world's largest wastewater study

A seven-year project monitoring illicit drug use in 37 countries via wastewater samples shows that cocaine use was skyrocketing in Europe in 2017 and Australia had a serious problem with methamphetamine.

Read more

A rat's brain, on and off methamphetamine

Drug addiction is a vicious cycle of reward and withdrawal. Chronic users often relapse because of the unpleasant physical and psychological symptoms they experience when they stop taking the drug. Now, researchers report metabolic changes in the brains of rats during methamphetamine self-administration and withdrawal that could help identify biomarkers and treatments for addiction.

Read more

Potential therapy to treat detrimental effects of marijuana

A new study using a preclinical animal model suggests that prenatal exposure to THC, the psychoactive component of cannabis, makes the brain's dopamine neurons (an integral component of the reward system) hyperactive and increases sensitivity to the behavioral effects of THC during pre-adolescence.

Read more

Cannabis study reveals how CBD offsets the psychiatric side-effects of THC

Researchers have shown for the first time the molecular mechanisms at work that cause cannabidiol, or CBD, to block the psychiatric side-effects caused by tetrahydrocannabinol (THC), the main psychoactive chemical in cannabis.

Read more